Philip Morris International (PM)
(Delayed Data from NYSE)
$125.62 USD
+0.97 (0.78%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $125.61 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$125.62 USD
+0.97 (0.78%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $125.61 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Zacks News
Philip Morris (PM) Down 5.4% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Will Altria (MO) Stock Recover on RRPs and Shareholder Moves?
by Zacks Equity Research
Altria (MO) consistently focuses on strengthening RRPs category to offset declining cigarette volumes. Its shareholder friendly moves bode well.
Top Analyst Reports for Philip Morris, ConocoPhillips & Alibaba
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Philip Morris (PM), ConocoPhillips (COP) and Alibaba (BABA).
All Rosy for Consumer Staples Stocks? Not Really
by Zacks Equity Research
The consumer staples space is grappling with rising input costs as well as intense competition, with the latter stemming from consumers' changing preferences.
Innovation, Buyouts & More to Fuel Consumer Staples Growth
by Zacks Equity Research
With growth hard to come by for companies in this mature space, Consumer Staples players have to remain focused on squeezing more out of their operations.
Is Phillip Morris' Weak Volumes a Concern for Tobacco Firms?
by vidya Nair
Weak shipment volumes stemming from declining cigarette sales have long been a hurdle for firms in the tobacco space. However, RRPs are likely to continue expanding.
Zacks Investment Ideas feature highlights: Phillip Morris International, Altria and British American Tobacco
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Phillip Morris International, Altria and British American Tobacco
Can Smokeless Unit Aid Altria (MO) This Earnings Season?
by Zacks Equity Research
Altria's (MO) first-quarter 2018 results are likely to benefit from RRPs. However, dismal cigarette volumes are a concern.
Philip Morris (PM) Tops Q1 Earnings, Ups '18 Earnings View
by Zacks Equity Research
Philip Morris's (PM) Q1 earnings came ahead of the Zacks Consensus Estimate while revenues missed the same.
Are Cigarettes Finally Dead? Phillip Morris Plunges
by David Borun
Despite beating estimates for net Q1 earnings, the international tobacco giant plunges, taking industry peers with
Philip Morris (PM) Q1 Earnings: Can RRPs Pare Cigarette Woe?
by Zacks Equity Research
Although Philip Morris (PM) continues to struggle with lower cigarette consumption, its first-quarter 2018 results are likely to gain from steady advancements in reduced risk products.
How MO & 3 Others Are Placed in a Challenging Tobacco Space
by vidya Nair
While stringent FDA regulations mar cigarette sales, tobacco firms are trying to stay afloat with RRPs.
What Philip Morris' Plant Conversion Could Mean for the Stock
by Zacks Equity Research
Philip Morris (PM) continues to enhance its RRPs category. The company announces plans to convert one of its cigarette production facilities in Greece for manufacturing smoke-free tobacco units.
Altria Loses 15% in a Year: Can Strategic Efforts Aid Growth?
by Zacks Equity Research
Amid numerous headwinds plaguing cigarette consumption, Altria (MO) manages to stay afloat in the industry on the back of smokeless products and strong pricing strategies.
Why Is Philip Morris (PM) Up 8.1% Since Its Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Will Philip Morris' Efforts to Expand RRPs Fuel Growth?
by Zacks Equity Research
Philip Morris (PM) strives to expand in the reduced risk products category as cigarette volumes continue to decline globally.
Why Earnings Season Could Be Great for Philip Morris (PM)
by Zacks Equity Research
Philip Morris (PM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Smokeless Unit & Pricing to Fuel Altria (MO) in Q4 Earnings?
by Zacks Equity Research
In 4Q17, we expect Altria (MO) to gain from strong pricing and focus on smokeless unit, though softness in its smokeable and wine segments remain concerns.
Can Philip Morris' (PM) RRPs Help It Tide Over Hurdles?
by Zacks Equity Research
Philip Morris (PM) continues to benefit from reduced risk products expansion efforts. However, declining cigarette consumption is a woe.
Can Altria's (MO) Focus on Smokeless Products Fuel Growth?
by Zacks Equity Research
Declining demand for tobacco products and stringent government regulations have been weighing upon Altria (MO). However, management has been actively working toward producing smokeless products.
Can Smokeless Unit Help Altria (MO) Make a Comeback in 2018?
by Zacks Equity Research
Although Altria (MO) has been grappling with issues stemming from stern regulations, the growing popularity of smokeless products up lifts hopes for the company's revival.
Will Philip Morris' Cigarette Category Continue to Struggle?
by Zacks Equity Research
Philip Morris (PM) has been struggling with lower cigarette sales volumes due to stringent government regulations surrounding tobacco consumption.
Can Altria's Efforts Offer Respite From Weak Smokeable Unit?
by Zacks Equity Research
Altria (MO) strengthens smokeless category amid industry-wide headwinds and declining tobacco consumption.
Can Philip Morris' Low Risk Products Counter Industry Woes?
by Zacks Equity Research
Phillip Morris (PM) invests in reduce risk products to counter low cigarette consumption.
Philip Morris (PM) Down 5.1% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Philip Morris (PM) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.